Header Logo

Connection

James Mulshine to Adenocarcinoma

This is a "connection" page, showing publications James Mulshine has written about Adenocarcinoma.
Connection Strength

0.209
  1. Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth. Exp Lung Res. 1998 Jul-Aug; 24(4):617-28.
    View in: PubMed
    Score: 0.143
  2. Expression of surfactant-associated protein in non-small-cell lung cancer: a discriminant between biologic subsets. J Natl Cancer Inst Monogr. 1992; (13):61-6.
    View in: PubMed
    Score: 0.023
  3. Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res. 1990 Sep 01; 50(17):5481-7.
    View in: PubMed
    Score: 0.021
  4. Insulin-like growth factor expression in human cancer cell lines. J Biol Chem. 1996 May 10; 271(19):11477-83.
    View in: PubMed
    Score: 0.008
  5. Cross validation of cluster analysis using immunostained multi-tissue tumour block slides. Br J Cancer Suppl. 1991 Jun; 14:60-3.
    View in: PubMed
    Score: 0.005
  6. Antibody 624H12, which detects lung cancer at early stages, recognizes a sugar sequence in the glycosphingolipid difucosylneolactonorhexaosylceramide (V3FucIII3FunLc6Cer). Arch Biochem Biophys. 1989 Nov 15; 275(1):309-14.
    View in: PubMed
    Score: 0.005
  7. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol. 1988 Dec; 90(6):641-52.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.